Seattle Children's
Anurekha Hall
Dr. Hall is a pediatric oncologist at Seattle Children’s Hospital and assistant professor at the University of Washington School of Medicine. She grew up in the Bay Area, received her undergraduate degree in biology from Northwestern University and then moved to Phoenix to teach second grade for two years through Teach for America. She received her medical degree from the University of Toledo College of Medicine, completed her pediatrics residency at Stanford University and moved to Seattle to complete her pediatric hematology oncology fellowship. Dr. Hall is a pediatric oncologist in the Cancer and Blood Disorders Center and the quality medical director of the Immune Effector Cell Program. She primarily cares for children being treated for leukemia or lymphoma and for children receiving chimeric antigen receptor T (CAR-T) cell therapies. Her research focuses on disparities in pediatric oncology, with a particular interest in disparities in access to, and outcomes in, advanced therapies that are only offered at limited sites, such as CAR-T cells and phase 1 clinical trials.
Adam Lamble
Adam Lamble, MD, is an attending physician at Seattle Children’s Hospital, Assistant Professor of Pediatrics at the University of Washington School of Medicine. Dr. Lamble’s clinical and research interests focus on high-risk hematologic malignancies and immune based therapies. He is a member of the Children’s Oncology Group (COG) myeloid diseases committee and is currently leading a Phase I clinical trial for pediatric patients with multiply relapsed acute myeloid leukemia (AML). Dr. Lamble provides consultations through both the High-Risk Leukemia Clinic and the Immunotherapy Team.
